Cortica, a San Diego, CA-based physician-led, value-based autism services company, raised $40M in Series D extension funding.
The round, which brought the total amount to $115M, was led by CVS Health Ventures, in conjunction with LRVHealth, Ascension Investment Management (a subsidiary of Ascension), and the University of Wisconsin Foundation.
The company intends to use the funds for continued national scaling of whole-child autism value-based care, as well as investments in technology, data capture, clinical decision support, research, and optimization of the clinician and patient experience.
Led by CEO and MD Neil Hattangadi, Cortica was founded to fix the fragmented care journey families typically experience when seeking diagnoses and treatments for autism. Its care model spans conditions that frequently co-occur with autism, including sleep disorders, seizures, psychiatric comorbidities, and gastrointestinal, communication, behavioral, and sensorimotor issues, among others, offering medical treatment, neurodiversity-affirming behavioral therapy, developmental therapy (encompassing speech, occupational, physical, and music therapies), and family support and counseling.
The company employs more than 1,800 experts across disciplines, including pediatric neurologists, developmental pediatricians, epileptologists, pediatric nurse practitioners, speech language pathologists, occupational therapists, physical therapists, music therapists, board certified behavior analysts, marriage and family therapists, and more. The researchers and physicians in its Cortica innovation network conduct outcomes research, serve as global leaders in clinical trial recruitment, and have assembled the largest long and wide dataset in autism and neurodevelopment.
FinSMEs
04/10/2023